Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Halometasone cream dose study in chronic generalized eczema
ChiCTR-OPH-17012348Phase 4Completed
- Sponsor
- Department of Dermatology, Beijing Friendship Hospital, Capital Medical University
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of halometasone in atopic dermatitis (AD) (3 arms), sponsored by Department of Dermatology, Beijing Friendship Hospital, Capital Medical University. Primary endpoints: EASI score, adverse events and 2 more. Started Jan 2017; status: completed.
02
Drugs
halometasone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR-OPH-17012348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPH-17012348.